tiprankstipranks
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (HK:2315)
:2315
Hong Kong Market
2315
Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H
RESEARCH TOOLSreports
Want to see HK:2315 full AI Analyst Report?

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H (2315) Balance Sheet

1 Followers

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H Balance Sheet

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H's total assets for Q4 2025 were ¥3.72B, an increase of 49.69% from the previous quarter. HK:2315 total liabilities were ¥1.54B for the fiscal quarter, a -2.92% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.
Balance Sheet
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Assets
¥ 3.72B¥ 2.42B¥ 2.45B¥ 2.80B¥ 2.30B
Total Liabilities
¥ 1.54B¥ 1.58B¥ 1.66B¥ 1.65B¥ 1.05B
Total Equity Gross Minority
¥ 2.18B¥ 838.60M¥ 790.44M¥ 1.15B¥ 1.25B
Other Metrics
Currency in CNY

Biocytogen Pharmaceuticals (Beijing) Co. Ltd. Class H Debt to Assets